Dynamics of the interaction of human IgG subtype immune complexes with cells expressing R and H allelic forms of a low-affinity Fc gamma receptor CD32A.
CD32A, the major phagocytic FcgammaR in humans, exhibits a polymorphism in the ligand binding domain. Individuals homozygous for the R allelic form of CD32A (CD32A(R) allele) are more susceptible to bacterial infections and autoimmune diseases as compared with H allelic CD32A (CD32A(H)) homozygous and CD32A(R/H) heterozygous individuals. To understand the mechanisms behind this differential susceptibility, we have investigated the dynamics of the interaction of these allelic forms of CD32A when they are simultaneously exposed to immune complexes (IC). Binding studies using Ig fusion proteins of CD32A alleles showed that the R allele has significantly lower binding not only to human IgG2, but also to IgG1 and IgG3 subtypes. Competition assays using purified molecules demonstrated that CD32A(H)-Ig outcompetes CD32A(R)-Ig for IC binding when both alleles simultaneously compete for the same ligand. CD32A(H)-Ig blocked the IC binding mediated by both the allelic forms of cell surface CD32A, whereas CD32A(R)-Ig blocked only CD32A(R) and was unable to cross-block IC binding mediated by CD32A(H). Two-dimensional affinity measurements also demonstrated that CD32A(R) has significantly lower affinity toward all three subtypes as compared with CD32A(H). Our data suggest that the lower binding of CD32A(R) not only to IgG2 but also to IgG1 and IgG3 might be responsible for the lack of clearance of IC leading to increased susceptibility to bacterial infections and autoimmune diseases. Our data further suggests that in humans, inflammatory cells from CD32A(R/H) heterozygous individuals may predominantly use the H allele to mediate Ab-coated target cell binding during phagocytosis and Ab-dependent cellular cytotoxicity, resulting in a phenotype similar to CD32A(H) homozygous individuals.
Shashidharamurthy
Rangaiah
R
Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA 30322, USA.
Zhang
Fang
F
Amano
Aaron
A
Kamat
Aparna
A
Panchanathan
Ravichandran
R
Ezekwudo
Daniel
D
Zhu
Cheng
C
Selvaraj
Periasamy
P
D000483:Alleles; D000818:Animals; D000936:Antigen-Antibody Complex / Q000235:genetics / Q000378:metabolism*; D001120:Arginine / Q000096:biosynthesis / Q000235:genetics*; D001327:Autoimmune Diseases / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D001424:Bacterial Infections / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D001667:Binding, Competitive / Q000235:genetics / Q000276:immunology; D016466:CHO Cells; D002460:Cell Line; D002462:Cell Membrane / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D006224:Cricetinae; D003412:Cricetulus; D019281:Dimerization; D020022:Genetic Predisposition to Disease; D006639:Histidine / Q000096:biosynthesis / Q000235:genetics*; D006801:Humans; D007074:Immunoglobulin G / Q000145:classification* / Q000235:genetics / Q000378:metabolism*; D008024:Ligands; D011110:Polymorphism, Genetic / Q000276:immunology; D011485:Protein Binding / Q000235:genetics / Q000276:immunology; D017452:Receptors, IgG / Q000096:biosynthesis* / Q000235:genetics* / Q000378:metabolism; D011993:Recombinant Fusion Proteins / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism
D000936:Antigen-Antibody Complex; C080568:Fc gamma receptor IIA; D007074:Immunoglobulin G; D008024:Ligands; D017452:Receptors, IgG; D011993:Recombinant Fusion Proteins; D006639:Histidine; D001120:Arginine